News & Updates

Show Multimedia Only
Intravenous PCA with hydromorphone outperforms oral morphine for severe cancer pain

Intravenous PCA with hydromorphone outperforms oral morphine for severe cancer pain

08 Oct 2024 byJairia Dela Cruz

In the management of severe cancer pain, intravenous patient-controlled analgesia (PCA) with hydromorphone delivers superior pain control with greater patient satisfaction as compared with conventional oral morphine, according to the phase III open-label SYLT-021 study.

Intravenous PCA with hydromorphone outperforms oral morphine for severe cancer pain

08 Oct 2024
4-year ischaemic stroke risk higher after patent foramen ovale closure

4-year ischaemic stroke risk higher after patent foramen ovale closure

08 Oct 2024
Physical activity, SBP tied to thoracic aortic size

Physical activity, SBP tied to thoracic aortic size

08 Oct 2024
Viral meningitis may induce developmental delays in kids

Viral meningitis may induce developmental delays in kids

08 Oct 2024